Literature DB >> 21326325

Molecular targets of phytochemicals for cancer prevention.

Ki Won Lee1, Ann M Bode, Zigang Dong.   

Abstract

Although successful for a limited number of tumour types, the efficacy of cancer therapies, especially for late-stage disease, remains poor overall. Many have argued that this could be avoided by focusing on cancer prevention, which has now entered the arena of targeted therapies. During the process of identifying preventive agents, dietary phytochemicals, which are thought to be safe for human use, have emerged as modulators of key cellular signalling pathways. The task now is to understand how these chemicals perturb these pathways by modelling their interactions with their target proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21326325     DOI: 10.1038/nrc3017

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  93 in total

1.  Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation.

Authors:  Kyung Mi Lee; Dong Eun Lee; Sang Kwon Seo; Mun Kyung Hwang; Yong-Seok Heo; Ki Won Lee; Hyong Joo Lee
Journal:  Carcinogenesis       Date:  2010-06-08       Impact factor: 4.944

2.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

3.  Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.

Authors:  Ming Li; Zhiwei He; Svetlana Ermakova; Duo Zheng; Faqing Tang; Yong-Yeon Cho; Feng Zhu; Wei-Ya Ma; Yuk Sham; Evgeny A Rogozin; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

4.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Authors:  Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Andre Robidoux; Therese B Bevers; Maureen T Kavanah; James N Atkins; Richard G Margolese; Carolyn D Runowicz; Joan M James; Leslie G Ford; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

5.  (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.

Authors:  Svetlana P Ermakova; Bong Seok Kang; Bu Young Choi; Hong Seok Choi; Todd F Schuster; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

6.  Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.

Authors:  I Avis; S H Hong; A Martinez; T Moody; Y H Choi; J Trepel; R Das; M Jett; J L Mulshine
Journal:  FASEB J       Date:  2001-07-09       Impact factor: 5.191

Review 7.  Taxanes: an overview of the pharmacokinetics and pharmacodynamics.

Authors:  U Vaishampayan; R E Parchment; B R Jasti; M Hussain
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

8.  Web services at the European Bioinformatics Institute-2009.

Authors:  Hamish McWilliam; Franck Valentin; Mickael Goujon; Weizhong Li; Menaka Narayanasamy; Jenny Martin; Teresa Miyar; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2009-05-12       Impact factor: 16.971

9.  Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin.

Authors:  Mun Kyung Hwang; Nu Ry Song; Nam Joo Kang; Ki Won Lee; Hyong Joo Lee
Journal:  Int J Biochem Cell Biol       Date:  2009-01-29       Impact factor: 5.085

10.  Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

Authors:  Douglas R Davies; Bjorn Mamat; Olafur T Magnusson; Jeff Christensen; Magnus H Haraldsson; Rama Mishra; Brian Pease; Erik Hansen; Jasbir Singh; David Zembower; Hidong Kim; Alex S Kiselyov; Alex B Burgin; Mark E Gurney; Lance J Stewart
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

View more
  125 in total

1.  A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.

Authors:  Haidan Liu; Kangdong Liu; Zunnan Huang; Chan-Mi Park; N R Thimmegowda; Jae-Hyuk Jang; In-Ja Ryoo; Long He; Sun-Ok Kim; Naomi Oi; Ki Won Lee; Nak-Kyun Soung; Ann M Bode; Yifeng Yang; Xinmin Zhou; Raymond L Erikson; Jong-Seog Ahn; Joonsung Hwang; Kyoon Eon Kim; Zigang Dong; Bo-Yeon Kim
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

2.  Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.

Authors:  Aishwarya Kundu; Jeanne G Quirit; Michelle G Khouri; Gary L Firestone
Journal:  Mol Carcinog       Date:  2016-02-15       Impact factor: 4.784

3.  Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells.

Authors:  Konstantin V Golovine; Peter B Makhov; Ervin Teper; Alexander Kutikov; Daniel Canter; Robert G Uzzo; Vladimir M Kolenko
Journal:  Prostate       Date:  2012-05-16       Impact factor: 4.104

4.  Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

5.  Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.

Authors:  Suman K Samanta; Anuradha Sehrawat; Su-Hyeong Kim; Eun-Ryeong Hahm; Yongli Shuai; Ruchi Roy; Subrata K Pore; Krishna B Singh; Susan M Christner; Jan H Beumer; Nancy E Davidson; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

6.  A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer.

Authors:  Jong-Eun Kim; Joe Eun Son; Hyein Jeong; Dong Joon Kim; Sang Kwon Seo; Eunjung Lee; Tae Gyu Lim; Jong Rhan Kim; Hanyong Chen; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Res       Date:  2015-05-06       Impact factor: 12.701

7.  [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2.

Authors:  Myoung Ok Kim; Mee-Hyun Lee; Naomi Oi; Sung-Hyun Kim; Ki Beom Bae; Zunnan Huang; Dong Joon Kim; Kanamata Reddy; Sung-Young Lee; Si Jun Park; Jae Young Kim; Hua Xie; Joydeb Kumar Kundu; Zae Young Ryoo; Ann M Bode; Young-Joon Surh; Zigang Dong
Journal:  Carcinogenesis       Date:  2013-11-26       Impact factor: 4.944

8.  The growth inhibitory effect of gambogic acid on pancreatic cancer cells.

Authors:  Mаhmoud Youns; Abeer ElKhoely; Rehab Kamel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-15       Impact factor: 3.000

Review 9.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

10.  Evaluation of Ceiba pentandra (L.) Gaertner bark extracts for in vitro cytotoxicity on cancer cells and in vivo antitumor activity in solid and liquid tumor models.

Authors:  Ravishankar Kumar; Nitesh Kumar; Grandhi V Ramalingayya; Manganahalli Manjunath Setty; Karkala Sreedhara Rangnath Pai
Journal:  Cytotechnology       Date:  2016-07-25       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.